Clinical trial · Observational
Study of Acquired Hemolytic Anemia in Adult Hospitalized Patients
Study of the Etiology, Clinical Features and Short Term Outcome of Acquired Hemolytic Anemia in Hospitalized Adult Patients with Non-Neoplastic Disease
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
the goal of the study is to identify the most common etiological factors and analyze the clinical presentations and laboratory findings in hospitalized patients with acquired hemolytic anemia associated with non-neoplastic diseases. And to evaluate short-term outcomes, including morbidity and mortality rates, and to determine correlations between specific etiological factors and patient outcomes in these cases.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hemolytic Anemia | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| blood samples | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- intensive care unit admission of the patients due to progression of the disease complications.
- timeFrame
- through study completion, an average of 6 months
- description
- Primary outcome will be ICU admission due to progression of the disease complications.
Secondary outcomes (1)
- measure
- mortality within duration of hospital admission
- timeFrame
- through study completion, an average of 6 months
- description
- Secondary outcome will be mortality within duration of hospital admission
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adults aged 18 years and older. * Patients diagnosed with acquired hemolytic anemia. * Patients must be hospitalized in the Internal Medicine department at the time of diagnosis of acquired hemolytic anemia during the study period * Patients (or their legal representatives) must provide informed Exclusion Criteria: * Patients with underlying neoplastic diseases. * Patients with hereditary hemolytic anemia. * Patients or their representatives who do not consent to participate in the study.
References
Publications (0)
Data not yet available